source
- ctDNA monitoring guides immunotherapy decisions in metastatic urothelial cancerExperts discussed how circulating tumor DNA (ctDNA) testing is being used to follow patients with metastatic urothelial carcinoma and to help shape immunotherapy choices. They noted that a rapid d…
- European regulators approve Fractyl Health's first GLP-1 gene therapy clinical trialEuropean regulators have given the green light for Fractyl Health, a biotech near Boston, to begin its first human study of a GLP-1 gene therapy. The therapy aims to provide a one-time treatment t…